αααααβααΎαSNYNF β’ OTCMKTS
add
Sanofi SA
111.61$
2 α§αααΆ, 8:10:00 PM ααααβααα -4 · USD · OTCMKTS · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
FR
αα·αααΈαα»α
111.61$
α
ααααααα½αααααΆαα
α»αααααα
91.81$ - 122.03$
ααΎαβαα»αβααΈααααΆα
136.48Β αααΈααΆα USD
ααα ααα½αααΌαααααα
7.54ααΆαα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
EPA
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
(EUR) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌα | 10.61Β αααΈααΆα | -4.61% |
α
αααΆαααααα·ααααα·ααΆα | 5.51Β αααΈααΆα | -2.37% |
α
αααΌααα»ααα | 1.87Β αααΈααΆα | 65.23% |
ααααΆααα
αααααα»ααα | β | β |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 1.02 | 7.45% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 2.90Β αααΈααΆα | 1.44% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 21.86% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
(EUR) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 7.56Β αααΈααΆα | -13.25% |
ααααααααα»α | β | β |
ααΆαααα½ααα»αααααΌαααα»α | β | β |
ααΌαβααααα»α | 77.86Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 1.25Β αααΈααΆα | β |
ααααααααααΉαααααα
| 1.81 | β |
ααα
ααααααΎαααααα | β | β |
ααα
ααααααΎααΎααα»α | 5.75% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
(EUR) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌααα»ααα | 1.87Β αααΈααΆα | 65.23% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | β | β |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | β | β |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | β | β |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | β | β |
ααα αΌαααΆα
αααααΆααααααα | β | β |
α’αααΈ
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with SynthΓ©labo in 1999 to form Sanofi-SynthΓ©labo. In 2004, Sanofi-SynthΓ©labo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the companyβs seat in Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
CEO
ααΆααααααΎαα‘αΎα
1973
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
82,878